GR 95168

Drug Profile

GR 95168

Alternative Names: ADDR 84231; C-BVDU

Latest Information Update: 27 Jan 1995

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antivirals; Nucleotides; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Herpes simplex virus infections; Varicella zoster virus infections

Most Recent Events

  • 27 Jan 1995 Discontinued-Preclinical for Herpes simplex virus infections in United Kingdom (Unknown route)
  • 27 Jan 1995 Discontinued-Preclinical for Varicella zoster virus infections in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top